BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Topics
»
Disease categories and therapies
» Neurology/psychiatric
Neurology/psychiatric
RSS
Mechanism-based enzyme inhibitor may serve as a lead for new anticonvulsants
Sep. 6, 1996
NS-2389: a potential new antidepressant
Sep. 6, 1996
Reversible MAO inhibitors from Hoechst Marion Roussel
Sep. 6, 1996
Lilly's olanzapine deemed approvable
Sep. 6, 1996
Antipsychotic dopaminergic compounds from E. Merck
Sep. 6, 1996
Lilly discloses new serotonergic agents
Sep. 6, 1996
NS-2710 in development for anxiety
Sep. 6, 1996
Melatonergic agents from ADIR
Sep. 6, 1996
BTG licenses analgesic combination to Forest
Sep. 6, 1996
FDA approves two pain products from Mallinckrodt
Sep. 6, 1996
Previous
1
2
…
2982
2983
2984
2985
2986
2987
2988
2989
2990
…
3022
3023
Next
RSS